Suven Life wins 8th product patent in Australia, Mexico

09 Sep 2010 Evaluate

Suven Life Sciences Ltd has been granted a product patent in Australia and Mexico for one of its new chemical entities for the treatment of disorders associated with neurodegenerative diseases. The patents are valid until 2023 and 2025, respectively.

The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents.The chemical entities are useful in the treatment of cognitive impairment associated with neurodegenerative disorders such as Alzheimer’s disease, attention deficient hyperactivity disorder, Huntington’s disease, Parkinson and Schizophrenia.

crackcrack

Suven Life Sciences Share Price

135.90 -4.90 (-3.48%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...